Weight Loss: A significant benefit of Semaglutide is its capacity to induce weight loss
This strategy is particularly compelling as the activity of these autoinhibitory factors is increased in obesity, hinting at an etiological role for them in leptin resistance [15, 48,49]
Available data suggest increased sensitivity to receptor activation in female physiology
Heart Diseases Hypertension Heart failure Cardiomyopathy Cardiac arrhythmias such as atrial fibrillation/flutter Endocrine Disorders Hypothyroid Hyperthyroid Parathyroid disorder Adrenal insufficiency Kidney Diseases Acute kidney failure Chronic kidney failure Electrolyte abnormalities Hypertension Lung Diseases Chronic obstructive pulmonary disease/emphysema Asthma Pulmonary fibrosis Reactive airway disease Pneumonias, and bronchitis Gastrointestinal Diseases Ulcerative colitis Crohn disease Irritable bowel syndrome Diarrhea Constipation Neurological Diseases Strokes Seizure disorders Movement disorders Neuropathies Post-stroke complications How GLP-1 Medications Work Semaglutide and Tirzepatide mimic natural hormones to regulate appetite, blood sugar, and metabolism creating the conditions for sustainable weight loss

Share your Precision Peptide Genetic Test results with your provider to discuss whether your compounded semaglutide formulation (30-day or extended-stability), refill schedule, and dose adjustments align with your genetic predispositions and treatment goals
Considering that many chronic age-related diseases appear to have some degree of mitochondrial dysfunction as part of their etiology, it is notable that alterations in mGSH homeostasis may be a central factor in this dysfunction